New Developments in the Diagnosis of Cutaneous Squamous Cell Carcinoma

Dear Colleagues,

Cutaneous squamous cell carcinoma (cSCC) stands as one of the most prevalent forms of skin cancer globally, representing a significant burden on healthcare systems and patients alike. With its incidence steadily rising over recent decades, the need for advancements in its diagnosis and management has become increasingly urgent. In response to this pressing demand, this Special Issue, titled "New Developments in the Diagnosis of Cutaneous Squamous Cell Carcinoma," aims to provide a comprehensive exploration of the latest advancements, innovations, and breakthroughs in the field.

cSCC, originating from the squamous cells of the skin's epidermis, presents various challenges in diagnosis due to its diverse clinical manifestations and potential for aggressive behavior, including metastasis. Traditional diagnostic methods, while effective to some extent, often fall short in accurately identifying and characterizing cSCC lesions, leading to delays in treatment initiation and suboptimal patient outcomes.

By delving into novel imaging techniques, molecular biomarkers, histopathological analyses, and emerging technologies, this collection of articles aims to shed light on promising avenues for improving the early detection, precise diagnosis, and personalized management of cSCC.

The goal of this Special Issue is to catalyze advancements in cSCC diagnosis that will translate into tangible benefits for patients, including the earlier detection of lesions, reduced morbidity and mortality rates, and an enhanced overall quality of life.

Through collaboration, innovation, and knowledge exchange, we strive to accelerate progress towards more effective strategies for combating this prevalent and potentially life-threatening skin cancer.

Dr. Sorina Danescu
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• cutaneous squamous cell carcinoma
• Bowen’s disease
• actinic keratosis
• diagnosis
• biomarkers
• imaging techniques
• molecular diagnostics
• histopathology
• precision medicine
• early detection